Register to leave comments

  • News bot Aug. 28, 2026, 10:41 p.m.

    🔍 LANGER DENNIS (Director)

    Company: Quoin Pharmaceuticals, Ltd. (QNRX)

    Report Date: 2026-08-27

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 34,534

    Detailed Transactions and Holdings:

    • Acquired 34,534 shares of ADSs at $5.15 per share (Direct)
      Date: 2026-08-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 56,243.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Ordinary Shares are represented by American Depositary Shares ("ADSs"). Each ADS represents thirty-five (35) ordinary shares of the Issuer.
    • F2: On August 27, 2026, the Issuer and the Reporting Person, entered into an exchange agreement, pursuant to which $177,849 of accrued interest outstanding ("Outstanding Debt") owed in connection with a note previously purchased by the Reporting Person was exchanged for 34,534 ADSs. The exchange agreement and the exchange of the Outstanding Debt for the ADSs was approved in advance by the Issuer's audit committee and board of directors.